17375-63-2
17375-63-2 結(jié)構(gòu)式
常見(jiàn)問(wèn)題列表
|
Human 5-HT 6 Receptor 20 nM (Ki) |
Human 5-HT 2A Receptor 69 nM (Ki) |
Human D 2 Receptor 140 nM (Ki) |
BGC20-761 has highly potent and selective 5-HT6 receptor antagonist activity; rat K i values for other rats receptors: 5-HT2A (470 nM), 5-HT2C (675 nM), D2, D3, D4, DAT and SERT (>10,000 nM).
BGC20-761 enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuospatial memory tasks through a 5-HT6 receptor-mediated mechanism. BGC20-761 (2.5 mg/kg, 5 mg/kg and 10 mg/kg; i.p.) alone has no effect on social recognition in young rats, however, at doses of 5 mg/kg and 10 mg/kg i.p, BGC20-761 dose-dependently reverses a deficit of social recognition induced by Scopolamine (0.4 mg/kg i.p.).
| Animal Model: | Forty-two male 8-week-old Longe Evans rats and 12 male four-week-old SpragueeDawley rats |
| Dosage: | 2.5 mg/kg, 5 mg/kg and 10 mg/kg |
| Administration: | Administered (i.p.) immediately after the training session for the social recognition test |
| Result: | Administered alone did not show any difference in social recognition as compared to saline treated control animals. However, 5 mg/kg and 10 mg/kg reversed a Scopolamine induced deficit in social recognition. |